1MANDREKAR S J, SCHILD S E, HILLMAN S L, et al. A prognostic model tbr advanced stage non small cell lung cancer. Pooled analysis of North Center Cancer Treatment Grouptrials~Jl. Cancer, 2006, 107(4): 781-792.
5FEUVRET L, NOEL G, MAZERON J J, et al. Conformity index: a review[J]. Int J Radiat Oncol Biol Phys, 2006, 64(2): 333-342.
6GRAHAM M V, PURDY J A, EMMA B, et al. Clinical dose- volume histogram analysis for penemonitis after 3D treatment tbr non-small cell lung cancer (NSCLC) [J]. lnt J Radiat Oncol Biol Phys, 1999, 45:3232-3239.
7ALLEN A M, HENNING G T, HAKEN 1", et al. Do dose-volume metrics predict pulmonary function changes in lung irradiation? [J] Int Radiat Oncol Biol Phys, 2003, 35: 921-929.
8WANG S, LIAO Z, WEI X, et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patient with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional confomlal radiotherapy (3D-CRT) [J]. lnt J Radiat Oncol Biol Phys, 2006, 66(5): 1399-1407.
